Longitude Capital โ Full Portfolio
99 tracked investments ยท listed companies and verified rows first
Veradermics is developing VDPHL01, an extended-release oral minoxidil tablet intended as a non-hormonal prescription treatment for pattern hair loss in women and men.
BiotechHealthtechWest Hartford, US
Reid Waldman(Chief Executive Officer and Board Member)inTim Durso(Chief Technical Officer)Dominic Carrano(Chief Financial Officer and Treasurer)Mark Neumann(Chief Commercial and Strategy Officer)John W. Childs(Director)Jane Grant-Kels(Director)
Co-investorsConnecticut InnovationsOUP (Osage University Partners)SR One Capital Management
Ceribell is a medical technology company that develops products for detecting and monitoring seizures, including EEG-based diagnostic systems.
AI & Machine LearningDigital HealthHealthtechMedical DevicesSunnyvale, US
Josef Parvizi(Director)Xingjuan Chao(Executive Officer, Director)Xingjuan (Jane) Chao(President, CEO, Co-Founder & Director)Scott Blumberg(Executive Officer)Joseph Taylor(Director)Raymond Woo(Executive Officer)
Board seatJuliet Tammenoms Bakkerยท per SEC Form D
Co-investorsRA CapitalRed Tree VentureShangBay Capital LLC
AEON Biopharma develops ABP-450 (prabotulinumtoxinA), a branded biosimilar to BOTOXยฎ, targeting therapeutic indications for neuromuscular conditions.
BiotechHealthtech
BIOAGE develops therapies targeting the molecular pathways that drive aging to increase healthspan and address age-related chronic diseases.
BiotechHealthtechLongevityRichmond, US
Kristen Fortney, PhD(Co-Founder, CEO)Eric Morgen, MD(Co-Founder, COO)Kristen Fortney(Executive Officer, Director)inEric Morgen(Director)Dov Goldstein(Executive Officer)
BoardPatrick Enright(Director)in
Co-investorsAndreessen HorowitzElad GilFelicis VenturesIA Seed VenturesOrbiMedPear VC+4 more
Boston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
HealthtechMedical Devices
Lance Batesin
Co-investorsAndera PartnersCouncilExcelestar VenturesGood Growth CapitalNew Enterprise Associates (NEA)Norwest Venture Partners+3 more
CG Oncology is a clinical-stage biotechnology company developing bladder-sparing oncolytic immunotherapies for patients with bladder cancer.
BiotechHealthtech
Co-investorsDecheng CapitalForesite CapitalPalm Drive CapitalRA CapitalTCG CrossoverACORN BIOVENTURES+2 more
Collegium Pharmaceutical is a biopharmaceutical company developing a portfolio of medications to treat serious medical conditions.
BiotechCanton, US
Michael Heffernan(Executive Officer, Director)Paul Brannelly(Executive Officer)
BoardEran Nadav(Director)John Freund(Director)Patrick Heron(Director)inDavid Hirsch(Director)
Co-investorsAPERTURE Venture PartnersEcoR1 CapitalFrazier Life Sciences
Corcept develops cortisol modulators โ molecules that regulate cortisol activity at the glucocorticoid receptor โ to treat serious diseases across endocrinology, oncology, metabolism, and neurology.
AI & Machine LearningBiotechHealthtechMedical Devices
Co-investorsMountain Group Capital
Clinical-stage biotechnology company developing conditionally activated, masked biologics designed to be localized to the tumor microenvironment.
BiotechSouth San Francisco, US
Sean McCarthy(Executive Officer, Director)
BoardTim Shannon(Director)inElaine V. Jones(Director)Neil Exter(Director)inFrederick W. Gluck(Director)Hoyoung Huh(Director)
Co-investorsCanaan PartnersThird Rock Ventures
BiotechArlington, US
Justin Hanes(Director)Kevin Pojasek(Executive Officer)Darius Kharabi(Executive Officer)Todd Bazemore(Executive Officer)Mark Iwicki(Executive Officer, Director)Mary Reumuth(Executive Officer)
Co-investorsSR One Capital ManagementYsios CapitalAtlas VentureLux CapitalThird Rock Ventures
Kestra Medical develops wearable defibrillator technology aimed at protecting patients at risk of sudden cardiac arrest through rapid defibrillation.
HardwareHealthtechMedical Devices
Co-investorsAndera PartnersBain Capital Life Sciences
Mobia Medical (formerly MicroTransponder) develops Vivistim Paired VNS Therapy, an FDA-approved treatment for stroke survivors with moderate to severe upper extremity impairment.
Digital HealthHealthtechMedical DevicesAustin, US
Richard John Foust(Executive Officer, Director)Frank McEachern(Executive Officer, Director)
BoardNelson Bunker Curnes(Executive Officer, Director)Thomas Jordan Curnes II(Executive Officer, Director)Casey Tansey(Director)Dana Mead(Director)
Co-investorsUT Horizon FundUS Venture Partners
RxSight develops the Light Adjustable Lens (LAL), an FDA-approved intraocular lens that surgeons can adjust after cataract surgery to fine-tune a patient's prescription once the eye has healed.
HealthtechMedical DevicesPasadena, US
Robert H. Grubbs(Director)Daniel M. Schwartz(Director)D. Verne Sharma(Executive Officer, Director)Richard Drinkward(Executive Officer)
BoardJavier Perez-Sala(Director)Jan Bonel(Director)
Co-investorsFlying L PartnersForesite CapitalH.I.G. CapitalH.I.G. HealthBridge PartnersRA CapitalVisionary Ventures+1 more
Vaxcyte develops broad-spectrum vaccines to prevent bacterial infections, using a cell-free protein synthesis platform and synthetic chemistry techniques.
BiotechHealthtech
Grant Pickering(Founder)in
Co-investorsBioRock VenturesCTI Life Sciences Fund L.P.Foresite CapitalFrazier Life SciencesRA Capital
Zenas BioPharma is a biopharmaceutical company developing therapies for autoimmune diseases, with two late-stage drug candidates: obexelimab, a bifunctional monoclonal antibody targeting CD19 and FcฮณRIIb to suppress B cell activity, and orelabrutinib, an oral BTK inhibitor.
BiotechHealthtechWaltham, US
LEON O. MOULDER, JR.(Director)Lonnie Moulder(Founder, CEO & Chairman)JOSEPH FARMER(Executive Officer)HUA MU(Executive Officer, Director)
BoardPATRICK GERALD ENRIGHT(Director)inHONGBO LU(Director)
Co-investorsDelos CapitalNew Enterprise Associates (NEA)Norwest Venture PartnersQuan CapitalSR One Capital ManagementVivo Capital+1 more
Alentis is a biotech company developing therapies for chronic liver disease, fibrosis, and cancer based on the molecular biology of liver disease.
AI & Machine LearningBiotechHealthtechMedical DevicesBasel, CH
Thomas Baumert(Founder)Mark Pruzanski(Chief Executive Officer)Luigi Manenti(Chief Medical Officer)Jon Freve(Chief Financial Officer)Bryan Yoon(General Counsel and Chief Administrative Officer)Aditya Venugopal(Chief Business Officer)
Co-investorsAvego BioScience CapitalBioMedPartnersFrazier Life SciencesJeito CapitalNovo HoldingsOrbiMed+5 more
Aviceda is a company that presents itself as backed by a range of investors, but the page provides no concrete details about its products or business area.
BiotechDigital HealthHealthtechMedical Devices
Mohamed A. Genead(Chairman & CEO)Jeffrey Nau(Chief Executive Officer)Tarek S. Hassan(Chief Development Officer)
Co-investorsJeito CapitalOrbiMedDigitalis Ventures
CuraSen Therapeutics is a privately funded biopharmaceutical company developing treatments that selectively activate adrenergic receptors in the brain to restore noradrenergic signaling.
BiotechHealthtech
Anthony Fordin
Co-investorsAlta Partnersabrdn plcIntermediate Capital GroupJohnson & Johnson Innovation โ JJDCNew Leaf Venture PartnersPappas Capital+2 more
Sydnexis is a privately held biopharmaceutical company developing SYD-101, a proprietary low-dose atropine formulation in Phase 3 clinical trials to slow the progression of pediatric progressive myopia.
BiotechDigital HealthDel Mar, US
Patrick Johnson(Executive Officer, Promoter)Mary Jaqueline Johnson(Executive Officer)Mary Jacqueline Johnson(Executive Officer)Kevin Johnson(Director)Greg Ostrow(Executive Officer, Director)Kenneth Widder(Executive Officer, Director)
Co-investorsRA CapitalVisionary Ventures
HealthtechIrvine, US
Robert E. Grant(Executive Officer, Director)Jeevan Gore(Executive Officer)Robert Rhatigan(Executive Officer)Craig Kussman(Executive Officer)
BoardWilliam Link(Chairman of the Board)Robert Hayman(Director)
Board seatJuliet Bakkerยท per SEC Form D ยท $40.5M raise ยท filed Jan 2015
Irvine, US
Michael Williamson(Executive Officer)Dan L. Dearen(Executive Officer)Michael V. Williamson(Executive Officer)Raymond W. Cohen(Executive Officer, Director)
BoardDarren Cai(Director)Raphael Wisniewski(Director)
Board seatJuliet Bakkerยท per SEC Form D ยท $55.1M raise ยท filed Apr 2018
Venus develops non-invasive, energy-based medical aesthetic devices for body, face, skin, and hair treatments, integrating robotics, AI, and IoT technologies.
BiotechHardwareHealthtechMedical DevicesToronto, US
Domenic Serafino(Executive Officer, Director)Kirk Gunhus(Executive Officer)Ross Portaro(Executive Officer)Anna Georgiadis(Executive Officer)Melissa Kang(Executive Officer)Michael Mandarello(Executive Officer)
Board seatJuliet Bakkerยท per SEC Form D
Co-investorsAPERTURE Venture PartnersEssex Woodlands Healthcare PartnersClarusHealthQuest Capital
89bio is a clinical-stage biopharmaceutical company developing therapies for patients with liver and cardiometabolic diseases.
Biotech
Co-investorsK2 HealthVentures
Co-investorsAisling Capital
Co-investorsFrazier Life SciencesOrbiMed
Akebia Therapeutics develops FDA-approved drug therapies for the treatment of kidney disease.
BiotechHealthtechMedical DevicesCambridge, US
John P. Butler(President and Chief Executive Officer)
Co-investorsCincyTech
Alpha-9 Oncology develops radiopharmaceuticals for cancer treatment, with a portfolio of molecules in clinical and preclinical development.
BiotechDigital HealthMedical DevicesVancouver, CA
Franรงois Bรฉnard(MD)Kuo-Shyan Lin(PhD)David Perrin(PhD)
Co-investorsAndreessen HorowitzDelos CapitalGeneral CatalystLightspeed Venture PartnersLumira VenturesNextech Invest+8 more
Amarin Corporation is a cardiovascular health pharmaceutical company developing treatments to prevent cardiovascular disease.
BiotechHealthtechMedical Devices
Co-investorsAvoro Capital AdvisorsFountain Healthcare PartnersSignet Healthcare PartnersSofinnova Ventures
HealthtechMaple Grove, US
Tom Ressemann(Executive Officer, Director)
BoardMichael Liang(Director)Robert Weisskoff(Director)inDan Sachs(Director)
Co-investorsF-Prime CapitalBaird CapitalHBM Healthcare Investments
BiotechEvanston, US
Joseph R. Moskal(Chief Scientific Officer)Torsten M. Madsen(Chief Marketing Officer)Ashish Khanna(Secretary & Chief Business Officer)Norbert G. Riedel(Chief Executive Officer)
BoardLiam Ratcliffe(Director)Terry P. Gould(Director)
Co-investorsBain Capital Life SciencesFrazier Life SciencesLatterell Venture PartnersOUP (Osage University Partners)
HealthtechMedia & EntertainmentMedical Devices
Co-investorsUS Venture Partners
Assembly Bio is a biotechnology company developing antiviral therapies for serious viral and liver diseases, including treatments for recurrent genital herpes and chronic hepatitis.
Biotech
Co-investorsAvoro Capital Advisors
BiotechCambridge, US
Mohamed Genead(Executive Officer, Director)Michael Tolentino(Executive Officer, Director)David Callanan(Executive Officer)Tarek Hassan(Executive Officer)Derek Kunimoto(Executive Officer)
BoardDavid Guyer(Director)
Co-investorsCatalio Capital Management, LPJeito Capital
Boston Scientific develops medical devices and technologies used by healthcare professionals to treat patients across a range of conditions.
HealthtechMedical Devices
Raymond Cohenin
Co-investorsAdvent Life SciencesAndera Partners
Non-surgical, non-pharmacologic devices to induce weight loss
Co-investorsDelos Capital
cAMPfield is a clinical-stage biopharmaceutical company developing prifemilast, a once-daily oral PDE4B-selective inhibitor for immune-mediated inflammatory diseases, primarily inflammatory bowel disease (ulcerative colitis and Crohn's disease).
BiotechHealthtech
Graham Heap(President, Research and Development)inEzequiel Neimark(Head of Clinical Development)inTaylor Spector(Head of Medical Affairs)inScott Stirn(Head of CMC)in
Co-investorsFrazier Life Sciences
Activating the immune system to recognize and destroy tumor cells.
BiotechCambridge, US
Art Krieg(Executive Officer, Director)Barry Labinger(Executive Officer, Director)Chuck Abdalian(Executive Officer)David Mauro(Executive Officer)Karen Brennan(Executive Officer)Charles Yon(Executive Officer)
Co-investorsF-Prime CapitalSofinnova VenturesNovo Holdings
Co-investorsSofinnova Ventures
BiotechChelsea, US
RICHARD BATYCKY(Executive Officer)GLENN BATCHELDER(Director)BRYAN STUART(Executive Officer)MARK IWICKI(Executive Officer, Director)MARTIN FREED(Executive Officer)
BoardROB HOPFNER(Director)
Co-investorsCanaan PartnersSofinnova VenturesBay City CapitalOrbiMedRA Capital
Cohere Health provides a platform aimed at aligning the interests of patients, physicians, and health plans to support care decisions and improve member outcomes.
AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechSaaSBoston, US
Siva Namasivayam(Executive Officer, Director)Robert Shepardson(Executive Officer)Kristen Carucci(Executive Officer)Duncan Reese(Executive Officer)
BoardDavid Barrett(Director)Amir Debourou(Director)
Co-investorsCota CapitalFlare Capital PartnersDeerfield Management CompanyDefine VenturesFlare Capital StrategiesTemasek
Cortica provides in-home, in-clinic, and telehealth neurological therapies for children with autism and developmental differences, integrating neurological, biomedical, behavioral, speech-language, and sensorimotor treatments.
Digital HealthHealthtechMedical DevicesSan Diego, US
Dr. Suzanne Goh(Founder)Neil Hattangadi(Executive Officer, Director)inBriana Elvaiah(Executive Officer)
BoardRyan Drant(Director)inStephen Anastos(Director)Justin Brock(Director)in
Co-investors.406 VenturesAIFAPERTURE Venture PartnersCVS Health VenturesEcho Health VenturesOptum Ventures+4 more
Gilead discovers, develops, and delivers innovative therapeutics for people with life-threatening diseases, focusing on virology, oncology, and inflammation across more than 35 countries.
BiotechDigital HealthHealthtechMedical DevicesFoster City, US
Lou Lange(Founder)Michael L. Riordan(Founder)inDaniel O'Dayin
Co-investorsAisling CapitalAsset Management CompanyFrazier Life SciencesKleiner PerkinsLumira VenturesMenlo Ventures+5 more
CytomX is a clinical-stage biopharmaceutical company developing conditionally activated biologic cancer therapies, including antibody-based treatments designed to target tumors while limiting effects on healthy tissue.
BiotechHealthtech
Sean A. McCarthy(Chief Executive Officer and Chairman)Marcia P. Belvin(SVP, Chief Scientific Officer)Dawn Benson(SVP, Quality and Product Manufacturing)Wayne Chu(Chief Medical Officer)Rachael Lester(SVP, Chief Business Officer)Chris Ogden(Chief Financial Officer)
Co-investorsCanaan PartnersPfizer Venture InvestmentsOrbiMed
Eargo was a hearing aid company that provided high-quality hearing aids and related care services.
HealthtechMedical DevicesMountain View, US
Raphael Michel(Executive Officer, Director)Christian Gormsen(Executive Officer, Director)William Brownie(Executive Officer)Peter Tuxen Bisgaard(Director)
BoardDavid Wu(Director)inJosh Makower(Director)
Co-investorsBirchmere VenturesMaveronNew Enterprise Associates (NEA)Dolby Family VenturesMontage VenturesRed Sea Ventures
Endeavor BioMedicines is a biopharmaceutical company developing medicines aimed at treating patients with serious, intractable diseases, with the goal of altering disease progression rather than only slowing it.
BiotechSan Diego, US
John Hood(Director, Executive Officer)inWing Cheong Lam(Director)Bernard Davitian(Director)Raghu Saripalli(Executive Officer)Monal Mehta(Director)Miguel de los Rios(Executive Officer)
Co-investorsFidelity Investments
Endogenex is a clinical-stage medical device company developing the pulsENDO system, which applies non-thermal pulsed electric field to reset the body's metabolic signaling and improve function in people with type 2 diabetes.
Digital HealthHealthtechMedical DevicesMinneapolis, US
Stacey Pugh(Leadership (CEO))Chris Sorli, MD, PhD(Chief Medical Officer)inKrissy Wright(Chief Financial Officer)inLian Cunningham, MD, PhD(VP Clinical Affairs)inMelanie Hess(Regulatory Affairs Leadership)inMatt Cambronne(Technical/Engineering Leadership)in
Co-investorsArboretum VenturesIntuitive VenturesLumira Ventures
Epirium Bio develops novel oral therapeutics targeting mitochondrial dysfunction and muscle diseases, particularly muscular dystrophy.
BiotechMedical DevicesSan Diego, US
Pam Taub(M.D., FACC, Founder)Alan Maisel(M.D., Founder)Francisco Villarreal(M.D., Ph.D., Founder)Jonathan Taub(Founder, Chief Executive Officer)Guillermo Ceballos(M.D., Founding Scientist)Russell J. Cox(President and CEO)
Co-investorsBluebird VenturesBroadview Ventures
BiotechAnn Arbor, US
Antonio M. Gotto, Jr.(Director)Tim M. Mayleben(Executive Officer, Director)Gilbert S. Omenn(Director)Daniel Janney(Director)Dov A. Goldstein(Director)Roger S. Newton(Director)
Co-investorsAisling CapitalAlta PartnersArboretum VenturesARCHIMED JapanAsset Management CompanyCanaan Partners+2 more
FIRE1 develops NORM, an implantable sensor placed in the inferior vena cava to directly measure fluid volume in heart failure patients, paired with a self-management platform to help patients engage with their own care.
Digital HealthHardwareMedical DevicesDublin, IE
Co-investorsAndera PartnersLightstone VenturesNew Enterprise Associates (NEA)Vensana Capital
Co-investorsKleiner Perkins
Helicore Bio develops long-acting antibody-peptide conjugate therapies for obesity and cardiometabolic disease, using proprietary GLP-1R agonist and amylin receptor agonist peptide libraries combined with a GIP ligand-binding antibody backbone.
BiotechHealthtech
Co-investorsOrbiMedVersant VenturesWellington Management
Infinant Health develops probiotic products based on B. infantis strains that work with breast milk to support the infant gut microbiome, including its INF108 drug strain aimed at preventing necrotizing enterocolitis (NEC) in premature infants.
BiotechDigital HealthFemTechHealthtechWellness & FitnessSacramento, US
J. Bruce German(Co-founder)David Mills(Co-founder)Carlito Lebrilla(Co-founder)Daniela Barile(Co-founder)Samara Freeman(Co-founder & Director of Intellectual Property and Regulatory Affairs)Michael Johnson(Executive Officer, Director)
Co-investorsAcre Venture PartnersBow CapitalHorizons VenturesiSelect FundBill & Melinda Gates FoundationSpruce Capital Partners
Co-investorsFountain Healthcare Partners
BiotechBoston, US
Axel Bolte(Executive Officer, Director)inReinaldo Diaz(Director)Joseph Schlessinger(Executive Officer, Director)
BoardEdward Mathers(Director)Rob Hopfner(Director)Martin Edwards(Director)
Co-investorsNew Enterprise Associates (NEA)Sanofi VenturesSofinnova VenturesPivotal Life Sciences
IntelyCare operates a healthcare talent marketplace that connects nurses with care settings including hospitals, clinics, and other healthcare facilities.
B2B MarketplacesFuture of WorkHealthtechHR TechQuincy, US
Ike Nnah(Executive Officer, Director)David Coppins(Executive Officer, Director)Prince Nnah(Director)
Co-investorsEastward Capital PartnersEndeavour VisionEquitage Ventures, L.L.C.Generator VenturesKaiser Permanente VenturesTRANSFORMATION CAPITAL+1 more
Jazz Pharmaceuticals is a biopharmaceutical company developing treatments for rare diseases and cancers, with a focus on oncology and biomarker-driven therapies such as those targeting HER2-expressing cancers.
BiotechHealthtech
Co-investorsProspect Venture PartnersRex Health VenturesSolas BioVentures
Lassen Therapeutics is a biotechnology company developing therapeutics targeting IL-11, with a pipeline focused on immune and fibrotic diseases.
Biotech
David King(Co-Founder & CSO)Maria Fardis(CEO)Cadmus C. Rich(Chief Medical Officer)Elaine Stracker(General Counsel)
Co-investorsAlta PartnersCatalio Capital Management, LPDC Investment PartnersLongwood FundBiotechnology Value FundCatalio Capital Management+2 more
Lexeo is a clinical-stage genetic medicine company developing gene therapies that target the genetic causes of cardiovascular diseases.
BiotechDigital HealthHealthtechNew York City, US
Ronald Crystal, MD(Founder & Chief Scientific Adviser)R. Nolan Townsend(Chief Executive Officer)Narinder Bhalla, MD(Chief Medical Officer)Josรฉ Manuel Otero, PhD(Chief Operating Officer)Louis Tamayo(Chief Financial Officer)
Co-investorsOrbiMed
LimFlow develops a medical device system for the treatment of chronic limb-threatening ischemia.
HealthtechMedical Devices
Co-investorsSofinnova Partners
Locus Biosciences develops engineered bacteriophage therapies for treating bacterial infections and conditions in immunology, oncology, and CNS disorders.
AI & Machine LearningBiotechDeep TechHealthtechRaleigh, US
Paul Garofolo(CEO & Co-founder)NICK TAYLOR(Executive Officer)PAUL GAROFOLO(Executive Officer, Director)Nick Conley(Vice President of Technology (Co-founder of EpiBiome, acquired by Locus))
BoardGEOFFREY GLASS(Director)DAVID JOHNSTON(Director)
Co-investorsArtis VenturesAbstract VenturesHemisphere Ventures LLCDomain AssociatesStarlight Ventures
Acquired by Shire in 2014 (now part of Takeda).
BiotechMedical Devices
Co-investorsFrazier Life SciencesOberland CapitalRiverVest Venture Partners
Molecular Templates, Inc. was a clinical-stage biopharmaceutical company formerly based in Austin, TX.
BiotechAustin, US
Co-investorsSofinnova VenturesSolasta Ventures
Murj provides a software platform for cardiac clinics, tailoring its solution to each clinic's specific workflows and challenges.
Digital HealthHealthtechMedical DevicesSaaSSanta Cruz, US
Patrick Beaulieu(Founder)inTodd Butka(Founder)
BoardMark Bartell(Director)Reed Gaither(Co-founder)
Co-investorsTrue Ventures
Co-investorsAisling CapitalEcoR1 Capital
Nalu Medical develops a non-integrated neurostimulation system that uses electrical impulses to interrupt pain signals for patients with intractable chronic nerve pain.
HardwareHealthtechMedical DevicesCarlsbad, US
Earl Fender(President & CEO)Lee Hartley(Executive Officer)Allen Meacham(Executive Officer)Bick Sellers(Executive Officer)Thomas A. West(Executive Officer, Director)Jeffrey Swiecki(Executive Officer)
Co-investorsAPERTURE Venture PartnersB Capital GroupB4 CapitalDecheng CapitalEndeavour VisionRunway Growth Capital+1 more
Developing a novel treatment for acute muscle spasms.
BiotechSan Diego, US
Kathleen D. Scott(Chief Financial Officer, Secretary and Treasurer)Judy Caron(Chief Operating Officer)David F. Hale(Chairman of the Board of Directors, Acting President and CEO)Brian Dorsey(Director)Daniel Becker(Director)Joshua Richardson(Director)
Co-investorsSofinnova VenturesH.I.G. HealthBridge Partners
NOCD provides specialized treatment for obsessive-compulsive disorder through live video sessions with OCD-trained therapists and 24/7 in-app support between sessions, using exposure and response prevention (ERP) therapy.
Digital HealthHealthtechMental HealthChicago, US
LARRY TRUSKY(Executive Officer)STEPHEN M. SMITH(Executive Officer, Director)Stephen Smith(Cofounder)
BoardGLEN TULLMAN(Director)in
Co-investors7wire VenturesChicago VenturesCorewell Health VenturesF-Prime CapitalKaiser Permanente VenturesMeridian Street Capital+2 more
NxStage provides home dialysis products and support for people with chronic kidney disease and end-stage renal disease, including home hemodialysis and peritoneal dialysis.
Digital HealthHardwareHealthtechMedical DevicesLawrence, US
Co-investorsCross Creek Advisors
On Belay provides tools, resources, and guidance to support primary care teams in transitioning to value-based care models and strengthening their practices across the United States.
Enterprise SoftwareHealthtechSaaS
Co-investors.406 VenturesMaverick Ventures
Co-investorsMenlo Ventures
Orbus Therapeutics is a clinical-stage biopharmaceutical company developing eflornithine (DFMO), an oral ODC inhibitor, as a cancer therapy.
BiotechHealthtechAptos, US
Jason Levin(Founder, Director and Chief Executive Officer)Jason D. Levin(Executive Officer, Director)Robert M. Myers(Executive Officer, Director)
BoardMichael Wasserman(Director)Patrick Enright(Director)Elisha (Terry) Gould(Director)
Co-investorsH.I.G. CapitalH.I.G. HealthBridge PartnersAgent Capital
BiotechMenlo Park, US
Mani Subramanian(Executive Officer, Director)Gangadhara Ganapati(Executive Officer, Director)
BoardMatthew Young(Director)inSrinivas Akkaraju(Director)Cory Freedland(Director)Edward Fleming(Director)
Co-investorsSamsara BioCapitalAscenta Capital
This page is a distribution, marketing, and reseller partner directory for PRWeb, an online press release distribution service.
Marketing TechMedia & EntertainmentSaaS
Co-investorsAdvance Venture PartnersAngel Physicians FundAvestria VenturesAviv Venture CapitalBIGR VenturesBlue Venture Funds+15 more
Polares Medical is a medical device company developing a device for treating mitral valve regurgitation.
HealthtechMedical DevicesPalo Alto, US
Alex Khairkhahan(Founder)in
Co-investorsDecheng CapitalEarlybird Venture CapitalEndeavour VisionIDO Investments
Poseida Therapeutics develops cell therapy candidates and related platform technologies for healthcare applications.
BiotechHealthtechSan Diego, US
Eric Ostertag(Executive Officer, Director)Mark Gergen(Executive Officer, Director)
BoardAdrian Howd(Director)David Hirsch(Director)
Co-investorsAisling CapitalRapha Capital Management, LLCVivo Capital
Practice Fusion provides a cloud-based electronic health record (EHR) platform with integrated medical billing services and e-prescribing for independent medical practices.
Digital HealthHealthtechSaaSSan Francisco, US
Ryan Howard(Executive Officer, Director)
BoardMark Goines(Director)Beth Seidenberg(Director)Michael Harden(Director)Cora Tellez(Director)
Co-investorsBand of AngelsCanvas Ventures
Quanta is a biotech company developing orally bioavailable, CNS-penetrant small-molecule KRAS inhibitors targeting RAS-driven cancers such as pancreatic, colorectal, lung, and endometrial cancers.
BiotechDeep TechHealthtechSouth San Francisco, US
Cameron Pitt(Executive Officer, Director)Derek Metzger(Executive Officer)
BoardMaha Katabi(Director)Perry Nisen(Executive Officer, Director)Maria Fardis(Director)Rajul Jain(Director)
Co-investorsSofinnova VenturesVida VenturesBiotechnology Value FundFrazier Life Sciences
Rivus Pharmaceuticals develops mitochondrial-targeted therapies to treat cardiometabolic diseases.
BiotechDigital HealthHealthtechMedical DevicesCharlottesville, US
Francisco Portell(Co-founder & Vice President, Pharmaceutical Development)Allen Cunningham(Co-founder & Chief Operating Officer)Nancy Hargreaves(Executive Officer)Jayson Dallas(Executive Officer, Director)Shaharyar Khan(Co-founder & Chief Scientific Officer)
BoardFrancesco De Rubertis(Director)in
Co-investorsMedicxiRA Capital
A biopharmaceutical company that discovers, develops, and delivers medicines and vaccines, with research and development across respiratory, immunology and inflammation, oncology, HIV, and infectious diseases.
BiotechHealthtechMedical DevicesSan Francisco, US
Co-investorsCapital Midwest FundFrazier Life SciencesRA CapitalVivo CapitalOxford Finance LLC
Solta Medical develops and sells a portfolio of aesthetic skin treatment devices, including the Thermage line, used by medical and cosmetic practices to address common skin concerns such as skin tightening and contouring.
HardwareMedical DevicesWellness & Fitness
Co-investorsNew Enterprise Associates (NEA)
Somatus provides value-based, integrated kidney care and a congestive heart failure management solution for patients, providers, and health plan partners.
Digital HealthHealthtechMclean, US
Ikenna Okezie(Executive Officer, Director)Alexander Houlday(Executive Officer)Stacey Queen-Pyndell(Executive Officer)
BoardAnna Haghgooie(Director)Anthony Welters(Director)
Co-investorsFlare Capital PartnersOptum VenturesHealthQuest CapitalBlue Venture FundsDefy PartnersRA Capital+4 more
Co-investorsAisling Capital
BiotechCambridge, US
William C. Shakespeare(Director)
BoardIain Dukes(Executive Officer, Director)inMichael Rome(Director)Carl Gordon(Director)in
Co-investorsForesite CapitalNextech InvestOrbiMed
BiotechHealthtech
Co-investorsClal Biotechnology IndustriesExSight VenturesTachyon VenturesThe Column Group
Co-investorsAvoro Capital AdvisorsScion Life SciencesTCG CrossoverVivo Capital
BiotechSouth San Francisco, US
Gerrit Klaerner(Executive Officer, Director)Melissa Miksch(Executive Officer)
BoardSandra Coufal(Director)David Bonita(Director)inKlaus Veitinger(Director)inRobert Alpern(Director)
Co-investorsAvoro Capital AdvisorsOrbiMed
BiotechSan Carlos, US
Surag Mantri(Executive Officer, Director)
BoardJustin Klein(Director)inMatthew Sprinkel(Director)Amir Abolfathi(Director)Varun Gupta(Director)
Co-investorsBoutique Venture PartnersNeotribe VenturesVensana Capital
Vera Therapeutics develops medicines targeting autoimmune-driven kidney diseases, with a focus on reducing the need for dialysis or transplant.
BiotechDigital HealthMedical Devices
Co-investorsKleiner PerkinsSofinnova Ventures
Viridian Therapeutics develops treatments for thyroid eye disease, a rare autoimmune condition affecting the eyes and orbit.
BiotechDigital HealthMedical DevicesWaltham, US
Jonathan Violin(Executive Officer, Director)
BoardPeter Harwin(Director)Tomas Kiselak(Director)
Co-investorsBroadview VenturesMRL Ventures Fund
WelbeHealth operates a Program of All-Inclusive Care for the Elderly (PACE) that provides integrated medical and social services to seniors, including primary care, dental, vision, hearing, in-home care, transportation, and social activities.
Digital HealthHealthtechWellness & FitnessCalifornia, US
Si France, MD(Founder)inCLANCY SI FRANCE(MANAGER AND CHIEF EXECUTIVE OFFICER OF ISSUER)
BoardLIAM DONOHUE(MANAGER OF ISSUER)ADAM GROFF(MANAGER OF ISSUER)MICHAEL ZUBKOFF(MANAGER OF ISSUER)JONATHAN LIM(MANAGER OF ISSUER)
Co-investors.406 VenturesGeneral Atlantic
Rows marked โSEC filingโ are inferred from directors named on the company's SEC Form D โ public regulatory data, not a portfolio list published by the firm.